Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2000, p. 2267-2270, Vol. 38, No. 6
Foodborne and Diarrheal Diseases Branch,
Division of Bacterial and Mycotic Diseases,1 and
Office of Minority and Women's Health, Office of the
Director,5 National Center for Infectious
Diseases, Epidemic Intelligence Service (EIS) Program,
Epidemiology Program Office,2 and Office
of Smoking and Health, Epidemiology Branch, National Center for Chronic
Disease Prevention and Health Promotion,3
Centers for Disease Control and Prevention, Atlanta, Georgia;
Meharry Medical College, Nashville,
Tennessee4; and Infectious Disease
Epidemiology and Surveillance Division, Texas Department of Health,
Austin, Texas6
Received 23 December 1999/Returned for modification 14 March
2000/Accepted 6 April 2000
Non-cholera Vibrio infections are an important public
health problem. Non-cholera Vibrio species usually cause
sporadic infections, often in coastal states, and have also caused
several recent nationwide outbreaks of gastroenteritis in the United
States. We report a survey of laboratory stool culturing practices for
Vibrio among randomly selected clinical laboratories in
Gulf Coast states (Alabama, Florida, Louisiana, Mississippi, and
Texas). Interviews conducted with the microbiology supervisors of 201 clinical laboratories found that 164 (82%) received stool specimens
for culture. Of these, 102 (62%) of 164 processed stool specimens on
site, and 20 (20%) of these 102 laboratories cultured all stool
specimens for Vibrio, indicating that at least 34,463 (22%) of 152,797 stool specimens were cultured for Vibrio.
This survey suggests that despite an increased incidence of non-cholera
Vibrio infections in Gulf Coast states, a low percentage of
clinical laboratories routinely screen all stool specimens, and fewer
than 25% of stool specimens collected are routinely screened for
non-cholera Vibrio.
0095-1137/00/$04.00+0
A Survey of Stool Culturing Practices for
Vibrio Species at Clinical Laboratories in Gulf Coast
States

*
Corresponding author. Mailing address: Meningitis and
Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., MS-CO9, Atlanta, GA 30333. Phone: (404) 639-4733. Fax: (404) 639-3106. E-mail: nbm8{at}cdc.gov.
Present address: Department of Medicine, University of California,
San Francisco, Calif.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»